Carey Gillam

About Carey Gillam

Carey Gillam is the editor-in-chief of The New Lede and a veteran investigative journalist with more than 30 years of experience covering US news, including 17 years as a senior correspondent with Reuters international news service (1998-2015). She is the author of “Whitewash - The Story of a Weed Killer, Cancer and the Corruption of Science,” an expose of Monsanto’s corporate corruption of agriculture. The book won the coveted Rachel Carson Book Award from the Society of Environmental Journalists in 2018. Her second book, a narrative legal thriller titled The Monsanto Papers, was released March 2, 2021. She also has contributed chapters for a text book about environmental journalism and a book about pesticide use in Africa. Gillam testified as an invited expert before the European Parliament in 2017 about her research, and was a featured speaker at the World Forum for Democracy in Strasbourg, France in 2019. She also has been a keynote and/or panel speaker at events and universities throughout North America, Australia, The Netherlands, Brussels, and France. Gillam writes regularly for The Guardian. Her work has additionally been published in The New York Times, Huffington Post, Time, and other outlets. In 2022, Gillam helped launch The New Lede as a journalism initiative of the Environmental Working Group. Gillam is a member of the Society of Environmental Journalists.

Posts by Carey Gillam:

Texas Standard

TNL Editor-in-Chief Carey Gillam talked with Texas Standard, a daily broadcast news show, about President Donald Trump’s actions to protect production of glyphosate, a common chemical used in the weedkiller Roundup.

Listen.

Not so fast – lawyers for cancer victims see “red flags” in Bayer’s $7.25 billion Roundup settlement deal

A group of 14 law firms representing nearly 20,000 plaintiffs is seeking to intervene in Bayer’s proposed class action settlement of Roundup litigation, citing concerns that the settlement deal will not be fair to cancer victims.

Bayer cites Trump support in Supreme Court Roundup battle

In an opening salvo aimed at convincing the US Supreme Court to curtail costly Roundup litigation, Bayer is citing support from President Donald Trump and US regulators while renewing a threat to stop sales of glyphosate-based herbicides to farmers if it does not prevail with the justices.

Trump enrages MAHA with order granting “immunity” to glyphosate pesticide production

In a move enraging health and environmental advocates, President Donald Trump has signed an executive order protecting production of and providing “immunity” for glyphosate-based herbicides, such as Roundup, which have been linked to cancer and are the subject of widespread US litigation.

WATCH: Bayer proposes $7.25 billion Roundup cancer settlement

Bayer has announced a proposed $7.25 billion class action settlement to address tens of thousands of U.S. lawsuits claiming its Roundup weedkiller caused cancer — including future cases. The deal must still be approved by the court and ties into a key Supreme Court fight over weedkiller warnings.

Bayer proposes $7.25 billion class action settlement in Roundup litigation

In a bold bid to put costly US Roundup litigation behind it, Bayer on Tuesday announced a $7.25 billion proposed class action settlement for users of its glyphosate-based weed killing products who have cancer now or develop cancer in the next several years, with average awards ranging from $10,000 to $165,000.

Supreme Court sets April hearing for Roundup preemption case

The US Supreme Court has set an April hearing in a closely watched case brought by Bayer that seeks to make the Environmental Protection Agency (EPA) the ultimate arbiter of warning labels on pesticides such as the company’s popular Roundup weed killer.

Florida tests show pesticide in popular breads

Florida officials this week unveiled test results showing multiple breads commonly sold in grocery stores contained residues of glyphosate weed killer, a chemical scientists have linked to cancer.

Citing Parkinson’s risk, Pennsylvania lawmakers push for paraquat ban

A contingent of Pennsylvania lawmakers and Parkinson’s disease research and support groups on Wednesday called for the state to move quickly to ban paraquat, a weed killing chemical commonly used by farmers that scientific research links to the incurable brain disease.

Syngenta settles bellwether US trial over paraquat links to Parkinson’s

On the eve of the opening of what would have been a bellwether US trial over allegations that a widely used weed killer causes Parkinson’s disease, paraquat-maker Syngenta reached a settlement with the retired landscaper who blamed the company for his diagnosis with the incurable brain disease.